Home
Healthcare
Medical Devices & Supplies
High Content Imaging Market Size, Share & Growth Report 2031

High Content Imaging Market

Name: Growth Market Reports
Address: 500 East E Street, Ontario, 91764, USA
Telephone: +1 909 414 1393

Segments - by Type (Instruments, Consumables, Software, and Services), By Application (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling, Other Applications), By End User (Pharmaceutical & Biotechnology Companies, Academic and Government Institutes, Contract Research Organization), and Regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast -2022-2030

HC-5337
4.4 Rating
239 Pages

25-04-2023
71 Reviews

Author :

Raksha Sharma

Fact-checked by :

Vineet Pandey

Editor :

Vishal Golekar

Report Description

High Content Imaging Market Outlook

The global high content imaging market size was estimated at USD 831.7 Mn in 2021 and is anticipated to reach USD 2,001.0 Mn by 2030, expanding at a CAGR of 10.5% during the forecast period, 2022-2030.

High content imaging is a highly automated three-step method that is used to significantly boost imaging throughput and quantification. These three steps are: Image Acquisition, Image Processing and Image Analysis. It uses fluorescent detection, multiparameter algorithms, automated microscopy, and automated microscopy to observe & measure the interaction of therapeutics in cell populations.

In it each cell in an array is examined at a sub-cellular resolution using multicolored fluorescence-based reagents for both specificity and sensitivity. High levels of computer-driven automation are linked to each stage, enabling users to speed up repetitive tasks and remove human bias from the workflow. Tera-bites of captured data are collected, processed, and analyzed in a matter of minutes with little assistance from humans.

High Content Imaging Market Macro-economic Factors

Rising GDP of Emerging Economies

An emerging market economy refers to a country that is in the process of development. Countries such as Brazil, Russia, India, China (BRIC), and other countries in Latin America & Southeast Asia are key developing economies.

The economic growth of emerging countries is typically growing by 6% to 7% annually, whereas countries with an already well-established economy report growth rates below 3%. Therefore, the GDP growth rates for emerging market economies are outperforming those of developed countries. Thus, the rising GDP of major & emerging economies plays a crucial role in the expansion of the market.

Governmental Spending

Governments across the globe are investing in the medical technology industry to increase real per capita healthcare spending. The medical technology industry is an essential component of the healthcare industry. Healthcare expenditure plays an important role in providing opportunities for maintaining health. It strengthens human capital and improves productivity, thereby contributing to economic performance. The medical technology industry registered an average global investment rate (R&D spending as a proportion of sales) of 8% in 2018.

High Content Imaging Market Dynamics

Major Drivers

Development of novel therapeutics against the SARS-CoV-2 virus

High-content imaging has been used as an efficient tool in identifying new lead compounds for antiviral drug development. Several high-throughput assays were developed and utilized during the early COVID-19 outbreak to scan collections of approved and investigational drugs in order to find possible anti-SARS-CoV-2 compounds.

A panel of assays was developed and used to screen collections of approved and investigational drugs for anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) activity in a quantitative high-throughput screening (qHTS) format in response to the COVID-19 pandemic. Prulifloxacin, tegobuvir, bictegravir, and nelfinavir have been identified by high-throughput screening (HTS) for drugs against 3CLpro.

Rising need for cost containment in pharmaceutical research and development

Drug development is a lengthy, complex, and costly process with a high degree of uncertainty of success. Pharmaceutical companies are being forced to reevaluate their R&D spending, due to the high cost and protracted nature of drug development. Toxicology studies are conducted by screening huge libraries for possible drug candidates. This approach is costly, and time- and resource-consuming, and it has a poor success rate.

High-content imaging solutions are used for testing the potential toxicity of chemicals and complex substances and are being adopted by pharmaceutical companies to advance in-vitro toxicity testing, which reduces the time and cost. This is expected to fuel the high-content imaging market during the forecast period.

Restraints

High Content Imaging should be ingested sparingly, as their excessive consumption can have negative effects on some people. High Content Imaging have negative health effects such as allergies, gastrointestinal problems, and an increase in insulin levels. High Content Imaging are anti-arrhythmic, which require patients to take a doctor’s approval before consuming High Content Imaging.

Excessive consumption of High Content Imaging can lead to calcification in the bones and other parts of the body. High Content Imaging overheat the body. Pregnant women are advised to avoid the consumption of an excessive amount of High Content Imaging to avoid any harm to the unborn child. Thus, side effects & allergies associated with the consumption of High Content Imaging can restrain the market.

Emerging Opportunities

High-content screening (HCS) is a well-established approach for the multiparametric analysis of cellular events. High-content imaging systems have evolved with many improvements to meet user demands of high flexibility and the growing requirements of assays involving complex cellular disease models.

Molecular Devices, LLC launched its next-generation, high-content imaging system, the ImageXpress Confocal HT.ai High-Content Imaging System, which is designed to help researchers advance phenotypic screening of 3D organoid models. Thus, technological advancements in high content imaging are expected to create opportunities for the market growth over the forecast period.

Scope of High Content Imaging Market Report

The report on the global High Content Imaging market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes	Details
Report Title	High Content Imaging Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast
Base Year	2021
Historic Data	2015–2020
Forecast Period	2022–2030
Segmentation	Product (Instruments, Consumables, Software, and Services), Application (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling, Other Applications), End User (Pharmaceutical & Biotechnology Companies, Academic and Government Institutes, Contract Research Organization)
Regional Scope	Regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)
Report Coverage	Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
Key Players Covered	PerkinElmer Inc, Thermo Fisher Scientific Inc, Agilent Technologies, Inc., Charles River Laboratories, Danaher (Molecular Devices, LLC), Yokogawa Electric Corporation, Miltenyi Biotec, Nikon Corporation (Nikon Instruments Inc), Zeiss Group (arivis AG), Aligned Genetics, Inc.

High Content Imaging Market Segmental Outlook

Product Segment Analysis

On the basis of product, the market is segmented into Instruments, Consumables, Software, and Services. Instruments are further subdivided into cell imaging & analysis systems and flow cytometers. Consumables are further subdivided into reagent & assay kits, microplates and other consumables.

The consumables segment is expected to hold a substantial share of the market during the forecast period, as it is helpful in providing high-performance imaging of a biological sample. High-content imaging systems use automated microscopy and fluorescent detection to visualize and quantify the interaction of therapeutics in cell populations.

Application Segment Analysis

Based on By Application, the market is fragmented into primary and Secondary screening, target identification and validation, toxicity studies, compound profiling and other applications. The target identification & validation segment is expected to hold a substantial share of the market during the forecast period, as HCI delivers a functional readout in target validation studies. Target validation shows that a molecular target is directly involved in a disease process and modulation of the target to have a therapeutic effect.

End User Segment Analysis

In terms of the End User, the market is fragmented into Pharmaceutical & Biotechnology Companies, Academic and Government Institutes, Contract Research Organization. The pharmaceutical & biotechnology company segment is projected to expand at a significant pace, as high-content imaging (HCI) is used in drug development and various clinical & preclinical studies. HCI systems have been witnessing strong demand in the pharmaceutical industry, due to the rising advancements in instrumentation techniques.

Regional Analysis

Based on regions, the market is separated into namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

The high growth of high-content imaging in the US is attributed to the rising demand for high-content imaging in the pharmaceutical industry. Government spending on the medical technology industry is anticipated to fuel the high-content imaging market over the forecast period. North America holds a significant instrument segment share. The market in the US is projected to continue registering high growth, owing to the rising use of technologically advanced tools in the drug development process.

The market in Asia Pacific is estimated to grow rapidly, owing to factors such as the increasing number of applications and the growing demand for high-content imaging. Rising research & development activities for medical technologies in many countries such as China and India are expected to contribute to the growth of the market in Asia Pacific.

The high-content imaging market in Latin America is estimated to expand at a considerable CAGR during the forecast period. Emerging economies in the region are expected to register significant growth, due to the growing demand for high-content imaging in compound profiling.

Key Benefits for Industry Participants & Stakeholders

In-depth Analysis of the Global High Content Imaging Market
Historical, Current, and Projected Market Size in terms of Value
Potential & Niche Segments and Regions Exhibiting Promising Growth Covered
Industry Drivers, Restraints, and Opportunities Covered in the Study
Recent Industry Trends and Developments
Competitive Landscape & Strategies of Key Players
Neutral Perspective on Global High Content Imaging Market Performance

Segments

Product

Instruments

Cell Imaging & Analysis Systems
Flow Cytometers

Consumables

Reagent & Assay Kits
Microplates
Other Consumables

Software
Services

Application

Primary and Secondary Screening
Target Identification and Validation
Toxicity Studies
Compound Profiling
Other Applications

End User

Pharmaceutical & Biotechnology Companies
Academic and Government Institutes
Contract Research Organization

Region

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Key Market Players Profiled in the Report

PerkinElmer Inc
Agilent Technologies, Inc
Thermo Fisher Scientific Inc
Charles River Laboratories
Danaher (Molecular Devices, LLC)
Yokogawa Electric Corporation
Miltenyi Biotec
Nikon Corporation (Nikon Instruments Inc),
Zeiss Group (arivis AG)
Aligned Genetics, Inc

Competitive Landscape

Manufacturers operating in the global high content imaging market include PerkinElmer Inc, Thermo Fisher Scientific Inc, Agilent Technologies, Inc., Charles River Laboratories, Danaher (Molecular Devices, LLC), Yokogawa Electric Corporation, Miltenyi Biotec, Nikon Corporation (Nikon Instruments Inc), Zeiss Group (arivis AG), Aligned Genetics, Inc.

Market Players are pursuing key strategies such as collaborations, mergers & acquisitions, and geographic expansion where a potential opportunity rises for the global high content imaging market.

High Content Imaging Market Key Players

Table Of Content

Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 High Content Imaging Market Overview
   4.1 Introduction
      4.1.1 Market Taxonomy
      4.1.2 Market Definition
      4.1.3 Macro-Economic Factors Impacting the Market Growth
   4.2 High Content Imaging Market Dynamics
      4.2.1 Market Drivers
      4.2.2 Market Restraints
      4.2.3 Market Opportunity
   4.3 High Content Imaging Market - Supply Chain Analysis
      4.3.1 List of Key Suppliers
      4.3.2 List of Key Distributors
      4.3.3 List of Key Consumers
   4.4 Key Forces Shaping the High Content Imaging Market
      4.4.1 Bargaining Power of Suppliers
      4.4.2 Bargaining Power of Buyers
      4.4.3 Threat of Substitution
      4.4.4 Threat of New Entrants
      4.4.5 Competitive Rivalry
   4.5 Global High Content Imaging Market Size & Forecast, 2016-2031
      4.5.1 High Content Imaging Market Size and Y-o-Y Growth
      4.5.2 High Content Imaging Market Absolute $ Opportunity
   4.6 Current and Future Trends
   4.7 Application of High Content Imaging in HCS Assays
   4.8 Application of High Content Imaging in Life Science Research
Chapter 5 Global High Content Imaging Market Analysis and Forecast By Product
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities By Product
      5.1.2 Basis Point Share (BPS) Analysis By Product
      5.1.3 Absolute $ Opportunity Assessment By Product
   5.2 High Content Imaging Market Size Forecast By Product
      5.2.1 Instruments
      5.2.2 Consumables
      5.2.3 Software
      5.2.4 Services
   5.3 Market Attractiveness Analysis By Product
Chapter 6 Global High Content Imaging Market Analysis and Forecast By Application
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities By Application
      6.1.2 Basis Point Share (BPS) Analysis By Application
      6.1.3 Absolute $ Opportunity Assessment By Application
   6.2 High Content Imaging Market Size Forecast By Application
      6.2.1 Primary and Secondary Screening
      6.2.2 Target Identification and Validation
      6.2.3 Toxicity Studies
      6.2.4 Compound Profiling
      6.2.5 Other Applications
   6.3 Market Attractiveness Analysis By Application
Chapter 7 Global High Content Imaging Market Analysis and Forecast By End User
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities By End User
      7.1.2 Basis Point Share (BPS) Analysis By End User
      7.1.3 Absolute $ Opportunity Assessment By End User
   7.2 High Content Imaging Market Size Forecast By End User
      7.2.1 Pharmaceutical & Biotechnology Companies
      7.2.2 Academic and Government Institutes
      7.2.3 Contract Research Organization
   7.3 Market Attractiveness Analysis By End User
Chapter 8 Global High Content Imaging Market Analysis and Forecast by Region
   8.1 Introduction
      8.1.1 Key Market Trends & Growth Opportunities by Region
      8.1.2 Basis Point Share (BPS) Analysis by Region
      8.1.3 Absolute $ Opportunity Assessment by Region
   8.2 High Content Imaging Market Size Forecast by Region
      8.2.1 North America
      8.2.2 Europe
      8.2.3 Asia Pacific
      8.2.4 Latin America
      8.2.5 Middle East & Africa (MEA)
   8.3 Market Attractiveness Analysis by Region
Chapter 9 Coronavirus Disease (COVID-19) Impact
   9.1 Introduction
   9.2 Current & Future Impact Analysis
   9.3 Economic Impact Analysis
   9.4 Government Policies
   9.5 Investment Scenario
Chapter 10 North America High Content Imaging Analysis and Forecast
   10.1 Introduction
   10.2 North America High Content Imaging Market Size Forecast by Country
      10.2.1 U.S.
      10.2.2 Canada
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 North America High Content Imaging Market Size Forecast By Product
      10.6.1 Instruments
      10.6.2 Consumables
      10.6.3 Software
      10.6.4 Services
   10.7 Basis Point Share (BPS) Analysis By Product
   10.8 Absolute $ Opportunity Assessment By Product
   10.9 Market Attractiveness Analysis By Product
   10.10 North America High Content Imaging Market Size Forecast By Application
      10.10.1 Primary and Secondary Screening
      10.10.2 Target Identification and Validation
      10.10.3 Toxicity Studies
      10.10.4 Compound Profiling
      10.10.5 Other Applications
   10.11 Basis Point Share (BPS) Analysis By Application
   10.12 Absolute $ Opportunity Assessment By Application
   10.13 Market Attractiveness Analysis By Application
   10.14 North America High Content Imaging Market Size Forecast By End User
      10.14.1 Pharmaceutical & Biotechnology Companies
      10.14.2 Academic and Government Institutes
      10.14.3 Contract Research Organization
   10.15 Basis Point Share (BPS) Analysis By End User
   10.16 Absolute $ Opportunity Assessment By End User
   10.17 Market Attractiveness Analysis By End User
Chapter 11 Europe High Content Imaging Analysis and Forecast
   11.1 Introduction
   11.2 Europe High Content Imaging Market Size Forecast by Country
      11.2.1 Germany
      11.2.2 France
      11.2.3 Italy
      11.2.4 U.K.
      11.2.5 Spain
      11.2.6 Russia
      11.2.7 Rest of Europe
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Europe High Content Imaging Market Size Forecast By Product
      11.6.1 Instruments
      11.6.2 Consumables
      11.6.3 Software
      11.6.4 Services
   11.7 Basis Point Share (BPS) Analysis By Product
   11.8 Absolute $ Opportunity Assessment By Product
   11.9 Market Attractiveness Analysis By Product
   11.10 Europe High Content Imaging Market Size Forecast By Application
      11.10.1 Primary and Secondary Screening
      11.10.2 Target Identification and Validation
      11.10.3 Toxicity Studies
      11.10.4 Compound Profiling
      11.10.5 Other Applications
   11.11 Basis Point Share (BPS) Analysis By Application
   11.12 Absolute $ Opportunity Assessment By Application
   11.13 Market Attractiveness Analysis By Application
   11.14 Europe High Content Imaging Market Size Forecast By End User
      11.14.1 Pharmaceutical & Biotechnology Companies
      11.14.2 Academic and Government Institutes
      11.14.3 Contract Research Organization
   11.15 Basis Point Share (BPS) Analysis By End User
   11.16 Absolute $ Opportunity Assessment By End User
   11.17 Market Attractiveness Analysis By End User
Chapter 12 Asia Pacific High Content Imaging Analysis and Forecast
   12.1 Introduction
   12.2 Asia Pacific High Content Imaging Market Size Forecast by Country
      12.2.1 China
      12.2.2 Japan
      12.2.3 South Korea
      12.2.4 India
      12.2.5 Australia
      12.2.6 South East Asia (SEA)
      12.2.7 Rest of Asia Pacific (APAC)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Asia Pacific High Content Imaging Market Size Forecast By Product
      12.6.1 Instruments
      12.6.2 Consumables
      12.6.3 Software
      12.6.4 Services
   12.7 Basis Point Share (BPS) Analysis By Product
   12.8 Absolute $ Opportunity Assessment By Product
   12.9 Market Attractiveness Analysis By Product
   12.10 Asia Pacific High Content Imaging Market Size Forecast By Application
      12.10.1 Primary and Secondary Screening
      12.10.2 Target Identification and Validation
      12.10.3 Toxicity Studies
      12.10.4 Compound Profiling
      12.10.5 Other Applications
   12.11 Basis Point Share (BPS) Analysis By Application
   12.12 Absolute $ Opportunity Assessment By Application
   12.13 Market Attractiveness Analysis By Application
   12.14 Asia Pacific High Content Imaging Market Size Forecast By End User
      12.14.1 Pharmaceutical & Biotechnology Companies
      12.14.2 Academic and Government Institutes
      12.14.3 Contract Research Organization
   12.15 Basis Point Share (BPS) Analysis By End User
   12.16 Absolute $ Opportunity Assessment By End User
   12.17 Market Attractiveness Analysis By End User
Chapter 13 Latin America High Content Imaging Analysis and Forecast
   13.1 Introduction
   13.2 Latin America High Content Imaging Market Size Forecast by Country
      13.2.1 Brazil
      13.2.2 Mexico
      13.2.3 Rest of Latin America (LATAM)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Latin America High Content Imaging Market Size Forecast By Product
      13.6.1 Instruments
      13.6.2 Consumables
      13.6.3 Software
      13.6.4 Services
   13.7 Basis Point Share (BPS) Analysis By Product
   13.8 Absolute $ Opportunity Assessment By Product
   13.9 Market Attractiveness Analysis By Product
   13.10 Latin America High Content Imaging Market Size Forecast By Application
      13.10.1 Primary and Secondary Screening
      13.10.2 Target Identification and Validation
      13.10.3 Toxicity Studies
      13.10.4 Compound Profiling
      13.10.5 Other Applications
   13.11 Basis Point Share (BPS) Analysis By Application
   13.12 Absolute $ Opportunity Assessment By Application
   13.13 Market Attractiveness Analysis By Application
   13.14 Latin America High Content Imaging Market Size Forecast By End User
      13.14.1 Pharmaceutical & Biotechnology Companies
      13.14.2 Academic and Government Institutes
      13.14.3 Contract Research Organization
   13.15 Basis Point Share (BPS) Analysis By End User
   13.16 Absolute $ Opportunity Assessment By End User
   13.17 Market Attractiveness Analysis By End User
Chapter 14 Middle East & Africa (MEA) High Content Imaging Analysis and Forecast
   14.1 Introduction
   14.2 Middle East & Africa (MEA) High Content Imaging Market Size Forecast by Country
      14.2.1 Saudi Arabia
      14.2.2 South Africa
      14.2.3 UAE
      14.2.4 Rest of Middle East & Africa (MEA)
   14.3 Basis Point Share (BPS) Analysis by Country
   14.4 Absolute $ Opportunity Assessment by Country
   14.5 Market Attractiveness Analysis by Country
   14.6 Middle East & Africa (MEA) High Content Imaging Market Size Forecast By Product
      14.6.1 Instruments
      14.6.2 Consumables
      14.6.3 Software
      14.6.4 Services
   14.7 Basis Point Share (BPS) Analysis By Product
   14.8 Absolute $ Opportunity Assessment By Product
   14.9 Market Attractiveness Analysis By Product
   14.10 Middle East & Africa (MEA) High Content Imaging Market Size Forecast By Application
      14.10.1 Primary and Secondary Screening
      14.10.2 Target Identification and Validation
      14.10.3 Toxicity Studies
      14.10.4 Compound Profiling
      14.10.5 Other Applications
   14.11 Basis Point Share (BPS) Analysis By Application
   14.12 Absolute $ Opportunity Assessment By Application
   14.13 Market Attractiveness Analysis By Application
   14.14 Middle East & Africa (MEA) High Content Imaging Market Size Forecast By End User
      14.14.1 Pharmaceutical & Biotechnology Companies
      14.14.2 Academic and Government Institutes
      14.14.3 Contract Research Organization
   14.15 Basis Point Share (BPS) Analysis By End User
   14.16 Absolute $ Opportunity Assessment By End User
   14.17 Market Attractiveness Analysis By End User
Chapter 15 Competition Landscape
   15.1 High Content Imaging Market: Competitive Dashboard
   15.2 Global High Content Imaging Market: Market Share Analysis, 2022
   15.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
      15.3.1 PerkinElmer Inc
      15.3.2 Thermo Fisher Scientific Inc
      15.3.3 Agilent Technologies, Inc
      15.3.4 Charles River Laboratories
      15.3.5 Danaher (Molecular Devices, LLC)
      15.3.6 Yokogawa Electric Corporation
      15.3.7 Miltenyi Biotec
      15.3.8 Nikon Corporation (Nikon Instruments Inc
      15.3.9 Zeiss Group (arivis AG)
      15.3.10 Aligned Genetics, Inc

Methodology

Purchase Premium Report

Buy Now

Request For Sample

Request For Customization

Enquiry Before Buying

Speak With Analyst

Customize This Report

Ask for Research To Be Focused On Specific Regions or Segments
Receive Data As Per Your Format and Definition
Companies Profiled based on Your Requirements
Breaking Down Competitive Landscape as per Your Requirements
Any Level of Customization

Our Clients

Client Testinomials

We needed a highly accurate and precise report, which Growth Market Reports delivered promptly. The company compiled information from a wide array of reliable agencies and sourcess.It is extremely satisfactory to be working with you.
Strategy Head of Major Tech Company

We were very pleased to contact Growth Market Reports as they tailored reports precisely as per our requirements. As we are dealing with the aerospace and defense industry, we need reports of high accuracy and substantial quality.
Major Player in Defense Industry

Extremely delighted to have a well-crafted report on “Global Packaging Solutions Market Research Report” from your team. Thank you for providing me with all our requirements and for incorporating our suggestions.
CMO of Leading Packaging Company from USA

I had a good experience working with Growth Market Reports as they were very open to all constructive changes in the report. I found that the report had its charm embedded with ample of data.
Founder and Managing Partner of Major Korean Company

Our company has been working with Growth Market Reports for some years now and we are very happy with the quality of the reports provided by the company.I, on behalf of my organization, would like to thank you for offering professional reports.
Global Consulting Firm

Quick Contact

+1 909 414 1393

sales@growthmarketreports.com

Growth Market Report

Certified By

FAQ Section

Some frequently asked questions about this report!

1. Which is the base year calculated in the global High Content Imaging market report and what is the analysis period?

The base year considered for the Global High Content Imaging Market report is 2021. The complete analysis period is 2015 to 2030, wherein, 2015 to 2020 are the historic years, and the forecast is provided from 2022 to 2030.

2. What additional data analysis is available in a report?

In addition to market size (in US$ Million), Company Market Share (in % for the base year 2021), macroeconomic factors, and supply chain analysis, current and future trends, application of high content imaging in HCS assays, application of high content imaging in life science research is given in the report.

3. What is the impact of COVID-19 on the overall market during the years 2019 -2020?

Pharmaceutical companies and medical researchers around the globe aim to fast-track drug discovery, development, and clinical trials in response to COVID-19, and are focusing on three key interventional strategies: repurposing of existing drugs, development of therapeutics, and development of vaccines.

4. Who are the major players operating in the market?

Major manufacturers include PerkinElmer Inc, Thermo Fisher Scientific Inc, Agilent Technologies, Inc., Charles River Laboratories, Danaher (Molecular Devices, LLC), Yokogawa Electric Corporation, Miltenyi Biotec, Nikon Corporation (Nikon Instruments Inc), Zeiss Group (arivis AG), Aligned Genetics, Inc.

5. Which macroeconomic factors affect the market?

Factors such as the rising GDP of Emerging Economies, Governmental Spending and R&D Activities are considered as macroeconomic factors for the report.

6. How big will be the global High Content Imaging market in 2030?

According to this Growth Market Reports report, the Global High Content Imaging Market is likely to register a CAGR of 10.5% during the forecast period 2020-2030, with a projected valuation of USD 2,001.0 Million by the end of 2030.

7. What are the factors driving the growth of the global High Content Imaging market?

Development of novel therapeutics against the SARS-CoV-2 virus, Rising need for cost containment in pharmaceutical research and development, Enhanced toxicity studies in cell analysis, and Rising use in medicinal products are the factors expected to drive the market growth during the forecast period.